FDA Warns of Increased Mortality Risk With Duvelisib

(MedPage Today) -- The FDA on Thursday warned about the possible increased risk of death or serious side effects with duvelisib (Copiktra) in adults with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL).
Long-term results from...